|
시장보고서
상품코드
1398756
유럽의 요도 벌킹 시스템 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 제품별, 최종사용자별, 국가별Europe Urethral Bulking Systems Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (Europe) |
||||||
유럽의 요도 벌킹 시스템 시장 규모는 크게 성장하여 2024년 2,500만 달러에서 2031년 말에는 약 4,200만 달러로 증가할 것으로 예상됩니다.
요도 벌킹 시스템은 여성에게 수치심과 불편함, 특히 사회생활에서 불편함을 유발하는 스트레스성 요실금을 치료하는 데 사용됩니다. 세계보건기구(WHO)와 의료 단체를 포함한 다양한 조직이 여성의 스트레스성 요실금에 대한 인식을 높이기 위해 노력하고 있으며, 이에 따라 치료 옵션에 대한 수용성이 높아지고 있습니다.
스트레스로 인한 요실금은 임산부들 사이에서 널리 퍼져 있으며, 임산부의 삶의 질에 영향을 미치고 있습니다. 많은 국가의 정부가 여성 스트레스성 요실금에 대한 인식을 적극적으로 홍보하고 있으며, 이는 요도 벌킹 시스템 판매 증가로 이어지고 있습니다. 스트레스성 요실금의 주요 위험 요인인 임신율 증가와 정부의 재정 지원은 시장 성장을 촉진할 것으로 예상됩니다.
고령 여성의 급격한 증가는 스트레스성 요실금 유병률 증가에 기여하는 중요한 요인입니다. 고령화는 스트레스성 요실금 사례의 증가와 밀접한 관련이 있습니다.
요실금 환자는 수술, 약물 치료, 카테터 치료, 신경 자극, 기구 사용 등 다양한 치료 옵션을 선택할 수 있습니다. 요실금 관리 제품과 같은 대체품의 가용성은 요도 벌킹 시스템 시장을 억제 할 수 있습니다.
요도 벌킹과 관련하여 요도하 농양, 요도탈출, 입자 이동 등의 심각한 부작용이 보고되고 있습니다. 이러한 합병증은 요도 벌킹 시스템의 보급에 있어 문제가 되고 있습니다.
이 보고서는 유럽의 요도 벌킹 시스템 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 최종사용자별, 국가별 동향, 시장 진입 기업의 경쟁 동향 등을 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 밸류체인 분석
- Porter's Five Forces 분석
- COVID-19의 영향 분석
- 우크라이나와 러시아의 분쟁의 영향
- 경제 개요
- PESTLE 분석
제3장 유럽의 요도 벌킹 시스템 시장 전망, 2018-2031년
- 유럽의 요도 벌킹 시스템 시장 전망, 제품별, 금액(100만 달러), 2018-2031년
- 유럽의 요도 벌킹 시스템 시장 전망, 최종사용자별, 금액(100만 달러), 2018-2031년
- 유럽의 요도 벌킹 시스템 시장 전망, 국가별, 금액(100만 달러), 2018-2031년
제4장 경쟁 상황
- 제품과 최종사용자 히트맵
- 제조업체와 최종사용자 히트맵
- 기업의 시장 점유율 분석, 2023년
- 경쟁력 대시보드
- 기업 개요
- Boston Scientific Corporation
- Coloplast Corporation
- Axonics Modulation Technologies, Inc.(Contura, Inc.)
- Palette Life Sciences, Inc.
- Laborie, Inc.
제5장 부록
ksm 24.01.05The Europe Urethral Bulking Systems Market is set to experience substantial growth, with revenue expected to increase from US$ 25 million in 2024 to approximately US$ 42 million by the end of 2031, according to the latest market analysis by Fairfield Market Research.
Understanding Urethral Bulking Systems
Urethral bulking systems are used to treat stress urinary incontinence, a condition that affects women and can cause embarrassment and discomfort, particularly in social settings. Various organizations, including the World Health Organization and healthcare groups, have worked to raise awareness about female stress urinary incontinence, increasing the acceptance of available treatment options.
Key Market Drivers
High Pregnancy Rate and Government Support: Stress urinary incontinence is prevalent among pregnant women, impacting their quality of life. Governments in many countries are actively promoting awareness about female stress urinary incontinence, leading to increased sales of urethral bulking systems. The rising pregnancy rate, a key risk factor for stress urinary incontinence, and government funding are expected to drive market growth.
Growing Geriatric Population: The rapid increase in the number of elderly women is a significant factor contributing to the rising prevalence of stress urinary incontinence. Aging is closely linked to an increase in stress urinary incontinence cases.
Awareness Initiatives: Several companies are actively engaged in raising awareness of incontinence and providing educational programs to healthcare workers and the general public. These initiatives aim to enhance understanding of urological problems, their causes, risk factors, and treatment options.
Market Challenges
Presence of Alternatives: Patients with stress urinary incontinence have various treatment options, including surgery, medication, catheterization, nerve stimulation, or device use. The availability of alternatives like incontinence care products may restrain the urethral bulking systems market.
Complications Associated with Urethral Bulking Systems: There have been reported cases of severe side effects associated with urethral bulking, including suburethral abscess, urethral prolapse, and particle migration. These complications pose challenges to the adoption of urethral bulking systems.
Market Insights for Germany
The German market is experiencing growth due to the increasing incidence of urethral incontinence in females. Key contributing factors include menopause, hysterectomy, pregnancy, childbirth, and changing lifestyles.
Outlook for the UK Market
In the UK, 24% of the female population is estimated to be affected by stress incontinence, according to the National Institute for Health and Care Excellence (NICE). This makes the UK a potentially lucrative market for manufacturers.
Competitive Landscape
Mergers and acquisitions have become primary growth strategies in the European urethral bulking systems market. Leading manufacturers are expanding their product lines through acquisitions and targeting both established and emerging markets. Key players are also focusing on growth, new product launches, and expanding their sales channels, including online sales.
Market Segmentation
Product:
- Pyrolytic carbon-coated graphite beads
- Calcium Hydroxylapatite Based
- Polydimethylsiloxane macroparticle
- Polyacrylamide hydrogel
- Hyaluronic Acid Based
End User:
- Hospitals
- Ambulatory Surgical centers
- Specialty Clinic
Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Benelux
- Nordic Countries
- Rest of Europe
Table of Contents
1. Executive Summary
- 1.1. Europe Urethral Bulking Systems Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter's Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
3. Europe Urethral Bulking Systems Market Outlook, 2018 - 2031
- 3.1. Europe Urethral Bulking Systems Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Pyrolytic carbon-coated graphite beads
- 3.1.1.2. Calcium Hydroxylapatite based
- 3.1.1.3. Polydimethylsiloxane macroparticle
- 3.1.1.4. Polyacrylamide hydrogel
- 3.1.1.5. Hyaluronic Acid Based
- 3.1.1. Key Highlights
- 3.2. Europe Urethral Bulking Systems Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Hospitals
- 3.2.1.2. Ambulatory Surgical centers
- 3.2.1.3. Specialty Clinic
- 3.2.1. Key Highlights
- 3.3. Europe Urethral Bulking Systems Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Germany Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.2. Germany Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1.3. U.K. Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.4. U.K. Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1.5. France Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.6. France Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1.7. Italy Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.8. Italy Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1.9. Turkey Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.10. Turkey Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1.11. Russia Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.12. Russia Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1.13. Rest of Europe Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
- 3.3.1.14. Rest of Europe Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
- 3.3.2. BPS Analysis/Market Attractiveness Analysis
- 3.3.1. Key Highlights
4. Competitive Landscape
- 4.1. Product vs End User Heatmap
- 4.2. Manufacturer vs End User Heatmap
- 4.3. Company Market Share Analysis, 2023
- 4.4. Competitive Dashboard
- 4.5. Company Profiles
- 4.5.1. Boston Scientific Corporation
- 4.5.1.1. Company Overview
- 4.5.1.2. Product Portfolio
- 4.5.1.3. Financial Overview
- 4.5.1.4. Business Strategies and Development
- 4.5.2. Coloplast Corporation
- 4.5.2.1. Company Overview
- 4.5.2.2. Product Portfolio
- 4.5.2.3. Financial Overview
- 4.5.2.4. Business Strategies and Development
- 4.5.3. Axonics Modulation Technologies, Inc. (Contura, Inc.)
- 4.5.3.1. Company Overview
- 4.5.3.2. Product Portfolio
- 4.5.3.3. Financial Overview
- 4.5.3.4. Business Strategies and Development
- 4.5.4. Palette Life Sciences, Inc.
- 4.5.4.1. Company Overview
- 4.5.4.2. Product Portfolio
- 4.5.4.3. Financial Overview
- 4.5.4.4. Business Strategies and Development
- 4.5.5. Laborie, Inc.
- 4.5.5.1. Company Overview
- 4.5.5.2. Product Portfolio
- 4.5.5.3. Financial Overview
- 4.5.5.4. Business Strategies and Development
- 4.5.1. Boston Scientific Corporation
5. Appendix
- 5.1. Research Methodology
- 5.2. Report Assumptions
- 5.3. Acronyms and Abbreviations
